Senior insider sale
President, R&D at TAKEDA PHARMACEUTICAL CO LTD — senior position signals high conviction
$2.51M
135.84K shares
What this filing means
PLUMP ANDREW STEWART plans to sell 135.84K shares of TAKEDA PHARMACEUTICAL CO LTD valued at approximately $2.51M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/2/2026ACC: 0001959173-26-006664
DirectorOfficer· President, R&D
Since Mar 2026
135.84K
Shares to sell
$2.51M
Approx. market value
116.19K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
RSU's and PSU's
N/A
8/20/2020
116.19KTotal acquired116.19K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/20/2020 | RSU's and PSU's N/A | 116.19K | — |
| Total | 116.19K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
19.65K
Market value
$363.3K
8/19/2026
Planned — Approximate Date
NYSEPlanned
Units to sell
116.19K
Market value
$2.15M
9/2/2026
Total
Units
135.84K
Value
$2.51M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/19/2026 | 19.65K | $363.3K | — | Completed |
| Planned — Approximate Date | ||||
9/2/2026 | 116.19K | $2.15M | NYSE | Planned |
| Total | 135.84K | $2.51M | ||